This property of the virus has been utilized to deliver GM-CSF to human B cells from B-cell chronic lymphocytic leukemia (B-CLL) patients as a potential immune therapy (Hellebrand et al., 2006). The gene discussed is CSF2; the disease is B-cell chronic lymphocytic leukemia.